| 000 | 01727 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516110207.0 | ||
| 264 | 0 | _c20130412 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1432-0851 | ||
| 024 | 7 |
_a10.1007/s00262-012-1342-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKnights, Ashley J | |
| 245 | 0 | 0 |
_aInhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cFeb 2013 |
||
| 300 |
_a321-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCancer Vaccines _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aThiazoles _xpharmacology |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aFucikova, Jitka | |
| 700 | 1 | _aPasam, Anupama | |
| 700 | 1 | _aKoernig, Sandra | |
| 700 | 1 | _aCebon, Jonathan | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 62 _gno. 2 _gp. 321-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-012-1342-1 _zAvailable from publisher's website |
| 999 |
_c22053124 _d22053124 |
||